Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-LDL Receptor antibody [301] - BSA and Azide free (ab276036)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [301] to LDL Receptor - BSA and Azide free
  • Suitable for: Flow Cyt
  • Reacts with: Human

Overview

  • Product name

    Anti-LDL Receptor antibody [301] - BSA and Azide free
    See all LDL Receptor primary antibodies

  • Description

    Rabbit monoclonal [301] to LDL Receptor - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    See all applications and species data

  • Immunogen

    Recombinant fragment (His-tag) corresponding to Human LDL Receptor aa 1-900. NP_000518.1
    Database link: P01130

  • Positive control

    • Flow Cyt: HepG2 cells.

  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

Images

  • Flow Cytometry - Anti-LDL Receptor antibody [301] (ab276036)
    Flow Cytometry - Anti-LDL Receptor antibody [301] (ab276036)

    Flow cytometric analysis of LDLR expression on HepG2 cells. Cells were stained with ab276036 (Black) at 1/25 dilution or an isotype control (Grey), then a FITC-conjugated secondary antibody. The histogram was derived from gated events with the forward and side light-scatter characteristics of intact cells.

  • Anti-LDL Receptor antibody [301] - BSA and Azide free (ab276036)
    Anti-LDL Receptor antibody [301] - BSA and Azide free (ab276036)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.